Literature DB >> 15622821

Postpartum depression: identification, screening, and treatment.

Jennifer Perfetti1, Roseanne Clark, Capri-Mara Fillmore.   

Abstract

Depression during the postpartum period is a significant public health concern, affecting 8%-15% of women and resulting in considerable morbidity for women, and their infants and families. Risk, prevalence, and distinguishing features of postpartum mood disorders are provided. Anxiety and depression frequently co-occur, suggesting symptoms of anxiety should also be attended to when screening for postpartum depression. Recommendations include the use of a brief, valid screening instrument as a routine clinical practice and the unique role of the obstetrician/gynecologist, pediatrician, and family practice physician in identification and referral. A summary of evidence-based treatment options for postpartum depression, along with current information about psychotropic medication, is provided to assist in risk-benefit analyses and decision making with patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15622821

Source DB:  PubMed          Journal:  WMJ        ISSN: 1098-1861


  14 in total

1.  Beyond Screening: A Stepped Care Pathway for Managing Postpartum Depression in Pediatric Settings.

Authors:  Su-Chin Serene Olin; Mary McCord; Ruth E K Stein; Bonnie D Kerker; Dara Weiss; Kimberly E Hoagwood; Sarah M Horwitz
Journal:  J Womens Health (Larchmt)       Date:  2017-04-14       Impact factor: 2.681

2.  Validity of depression rating scales during pregnancy and the postpartum period: impact of trimester and parity.

Authors:  Shuang Ji; Qi Long; D Jeffrey Newport; Hyeji Na; Bettina Knight; Elizabeth B Zach; Natalie J Morris; Michael Kutner; Zachary N Stowe
Journal:  J Psychiatr Res       Date:  2010-06-09       Impact factor: 4.791

3.  Robust estimation of area under ROC curve using auxiliary variables in the presence of missing biomarker values.

Authors:  Qi Long; Xiaoxi Zhang; Brent A Johnson
Journal:  Biometrics       Date:  2010-09-03       Impact factor: 2.571

Review 4.  Can Postpartum Depression Be Managed in Pediatric Primary Care?

Authors:  Su-Chin Serene Olin; Bonnie Kerker; Ruth E K Stein; Dara Weiss; Emma D Whitmyre; Kimberly Hoagwood; Sarah M Horwitz
Journal:  J Womens Health (Larchmt)       Date:  2015-11-18       Impact factor: 2.681

5.  Auricular Treatment of Maternal Depressive Disorders.

Authors:  Nader Soliman
Journal:  Med Acupunct       Date:  2019-10-17

6.  Validating the Edinburgh Postnatal Depression Scale as a screening tool for postpartum depression in Kathmandu, Nepal.

Authors:  Babu Ram Bhusal; Nisha Bhandari; Manisha Chapagai; Tania Gavidia
Journal:  Int J Ment Health Syst       Date:  2016-10-21

7.  Risk factors associated with postpartum depression in the Saudi population.

Authors:  Abeer A Alharbi; Hamza Mohammad Abdulghani
Journal:  Neuropsychiatr Dis Treat       Date:  2014-02-17       Impact factor: 2.570

8.  Genetic variants in the genes of the stress hormone signalling pathway and depressive symptoms during and after pregnancy.

Authors:  Michael Schneider; Anne Engel; Peter A Fasching; Lothar Häberle; Elisabeth B Binder; Franziska Voigt; Jennifer Grimm; Florian Faschingbauer; Anna Eichler; Ulf Dammer; Dirk Rebhan; Manuela Amann; Eva Raabe; Tamme W Goecke; Carina Quast; Matthias W Beckmann; Johannes Kornhuber; Anna Seifert; Stefanie Burghaus
Journal:  Biomed Res Int       Date:  2014-03-12       Impact factor: 3.411

9.  Early identification of women at risk of postpartum depression using the Edinburgh Postnatal Depression Scale (EPDS) in a sample of Lebanese women.

Authors:  Charline El-Hachem; Jihane Rohayem; Rami Bou Khalil; Sami Richa; Assaad Kesrouani; Rima Gemayel; Norma Aouad; Najat Hatab; Eliane Zaccak; Nancy Yaghi; Salimé Salameh; Elie Attieh
Journal:  BMC Psychiatry       Date:  2014-09-07       Impact factor: 3.630

10.  Self-Harm Thoughts Postpartum as a Marker for Long-Term Morbidity.

Authors:  Stavros I Iliadis; Alkistis Skalkidou; Hanna Ranstrand; Marios K Georgakis; Cathrine Axfors; Fotios C Papadopoulos
Journal:  Front Public Health       Date:  2018-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.